The increasing fear of drug-resistant pathogens is leading to a growing push for the next generation of antibiotics. The enhancement of new antibiotics is crucial to control the current and future infectious diseases caused by antibiotic resistant bacteria. The discovery of a new antibiotic called teixobactin was revealed by international team of researchers in 2017. The researchers now intend on analyzing the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5–10% of all hospitalizations are perplexed by a nosocomial disease with an expected cost of$4.5–5.7 billion every year in the USA alone. More kinds of biological solution are yet to be discovered in this field.
Related: Antibiotics Conference, Antimicrobial Resistance Congress, Antibiotics Meetings, Antibiotics Event, Drug Resistance Congress, Antibiotic Resistance, Antimicrobial Event, Antibiotics Summit, Antimicrobial Resistance Conference.
Related Conferences: 19th World Congress on Advances in Pharmaceutical Sciences on October 14-15, 2019 Seoul, South Korea; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance on June 03-04, 2019, London, UK; 16th International Conference on Pharmaceutical Formulations & Drug Delivery on October 23-24, 2019 Amsterdam, Netherlands.
Related Associations: Alliance for the Prudent Use of Antibiotics, Global Antibiotic Resistance Partnership, Infectious Diseases Society of America, Antibiotic Research UK, The World Alliance Against Antibiotic Resistance, Australian Society of Antimicrobials, Centers for Disease Control and Prevention and Chinese Society for Microbiology.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
